Parabase Genomics
Hardwick
About Parabase Genomics
Parabase Genomics is a privately held molecular diagnostics company focused on changing the way newborns and children with genetic disorders are diagnosed and treated. The Company’s NewbornDx™ test is designed to guide the differential diagnosis of common symptomology found in neonates. It allows a physician to utilize one test to provide an accurate molecular profile on 500+ newborn related genes using dried blood spots within 10 days. Physicians no longer need to depend on severe phenotypes to nominate a single gene test for a given disorder.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $3.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Nov 2014)
- Website: parabasegenomics.com
- Phone: (857)288-0838
Industries & Categories
Biotechnology, Genetics, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/parabase-genomics-1227994 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.